The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the What's New section. Go check it out! Check out the Communication page for a complete list of forms or by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...